Sulindal

S OPEN Abstracts from the 2017 Respiratory Effectiveness Group Summit: what lies ahead? Translating the value and potential of… Expand

Although highly active antiretroviral therapy has enabled constant progress in reducing HIV-1 replication, in some patients who… Expand

Since the presentation of the D:A:D study results at the Conference on Retroviruses and Opportunistic Infections in February 2008… Expand

Abstract Objective: To identify predictors of improved asthma control under conditions of everyday practice in Switzerland… Expand

(1) Rofecoxib, a nonsteroidal antiinflammatory drug, is licensed in France for symptom relief in osteoarthritis. It is promoted… Expand

 

 

Aceclidine hydrochloride (3-acetoxyquinuclidine, "Glaucostat": Chibret) used topically in a strength of 2 per cent. is a… Expand